Low-dose clozapine improves dyskinesias in Parkinson's disease
- PMID: 9065543
- DOI: 10.1212/wnl.48.3.658
Low-dose clozapine improves dyskinesias in Parkinson's disease
Abstract
The severity of parkinsonian motor disability and dyskinesias was evaluated in seven levodopa-responsive patients with Parkinson's disease after an acute challenge with the mixed dopamine agonist apomorphine, before and after low-dose clozapine (50 mg) for 18 +/- 2 days. There was a significant 59% improvement (p < 0.05) of apomorphine-induced dyskinesias without aggravation of parkinsonian motor disability following clozapine treatment. The results suggest that low-dose clozapine, already shown to improve psychotic symptoms, may help to reduce severe levodopa-induced dyskinesias in parkinsonian patients.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical